Skip to main content

Fred Hutchinson Center Plans Lab Support, Office Uses for New Building

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center said it will use a newly-acquired building adjacent to its campus in Seattle's South Lake Union section for research support facilities as well as offices — and possibly could expand its lab research space as a result.

"This offers an outstanding opportunity to expand our solid tumor, infectious disease, and immunotherapy research as well as work toward the goal of consolidating all of the Center's research activities onto one campus," Doug Walker, chairman of the Hutchinson Center's board, said in a statement.

The Hutchinson Center paid $36 million to acquire the 177,000-square-foot building, at 1100 Eastlake Ave. E., from the Blume 1100 Partnership, a group of investors led by Seattle developer Bruce Blume, CEO of The Blume Company

The Hutchinson Center said in the statement that it plans to occupy the building in June 2012.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.